1. Home
  2. PTLE vs BIAF Comparison

PTLE vs BIAF Comparison

Compare PTLE & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTLE
  • BIAF
  • Stock Information
  • Founded
  • PTLE 2013
  • BIAF 2014
  • Country
  • PTLE Singapore
  • BIAF United States
  • Employees
  • PTLE N/A
  • BIAF N/A
  • Industry
  • PTLE Oil Refining/Marketing
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • PTLE Energy
  • BIAF Health Care
  • Exchange
  • PTLE Nasdaq
  • BIAF Nasdaq
  • Market Cap
  • PTLE 8.0M
  • BIAF 6.6M
  • IPO Year
  • PTLE 2024
  • BIAF 2022
  • Fundamental
  • Price
  • PTLE $0.17
  • BIAF $1.46
  • Analyst Decision
  • PTLE
  • BIAF Hold
  • Analyst Count
  • PTLE 0
  • BIAF 1
  • Target Price
  • PTLE N/A
  • BIAF N/A
  • AVG Volume (30 Days)
  • PTLE 34.7M
  • BIAF 137.0K
  • Earning Date
  • PTLE 11-03-2025
  • BIAF 11-14-2025
  • Dividend Yield
  • PTLE N/A
  • BIAF N/A
  • EPS Growth
  • PTLE N/A
  • BIAF N/A
  • EPS
  • PTLE N/A
  • BIAF N/A
  • Revenue
  • PTLE $91,415,732.00
  • BIAF $6,776,739.00
  • Revenue This Year
  • PTLE N/A
  • BIAF N/A
  • Revenue Next Year
  • PTLE N/A
  • BIAF $20.04
  • P/E Ratio
  • PTLE N/A
  • BIAF N/A
  • Revenue Growth
  • PTLE N/A
  • BIAF N/A
  • 52 Week Low
  • PTLE $0.14
  • BIAF $1.25
  • 52 Week High
  • PTLE $15.78
  • BIAF $46.53
  • Technical
  • Relative Strength Index (RSI)
  • PTLE 44.79
  • BIAF 34.99
  • Support Level
  • PTLE $0.18
  • BIAF $1.91
  • Resistance Level
  • PTLE $0.20
  • BIAF $1.57
  • Average True Range (ATR)
  • PTLE 0.04
  • BIAF 0.20
  • MACD
  • PTLE -0.00
  • BIAF -0.06
  • Stochastic Oscillator
  • PTLE 6.18
  • BIAF 20.38

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, serving the Asia Pacific market. The company's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers on time; and handling disputes, mainly concerning quality and quantity issues on marine fuel. The company derives its maximum revenue from Hong Kong.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: